Cardiac conduction system cells and uses thereof

• US 7,960,173 B2
• Filed: 05/25/2007
• Issued: 06/14/2011
• Est. Priority Date: 06/10/2004
• Status: Expired due to Fees

• Current Assignee: Board of Supervisors of Louisiana State University Agricultural & Mechanical College (Louisiana State University System)
• Original Assignee: Board of Supervisors of Louisiana State University Agricultural & Mechanical College (Louisiana State University System)
• Inventors: White, Steven M., Claycomb, William C.
• Primary Examiner(s): Ton; Thaian N
• Assistant Examiner(s): SGAGIAS, MAGDALENE K
• Application Number:
  US11/753,719
• Publication Number:
  US 20070239136A1
• Time in Patent Office: 1,481 Days
• Field of Search: 435/325, 536/23.1
• US Class Current: 435/325
• CPC Class Codes: C12N 2506/02 from embryonic cells
• CPC Class Codes: C12N 2510/00 Genetically modified cells
• CPC Class Codes: C12N 5/0657 Cardiomyocytes; Heart cells

Abstract

Isolation and amplification of cardiac pacemaking/conduction system cells and development of a pacemaking/conduction system in vitro using the expression of surrogate expression markers. Use of markers to identify and select for clusters of pacemaking “nodes” that are functionally coupled with adjacent contracting regions and generation of cell populations displaying electrical properties characteristic of specialized pacemaking/conducting cardiac myocytes for modeling the cardiac conduction system, testing of pharmaceuticals and for transplantation.

Claims

1. A pure, isolated population of cardiac pacemaking cells that after multiple cell passages retain one or more cardiac pacemaking characteristics selected from the group consisting of expression of a voltage-gated calcium current and expression of a hyperpolarization-activated pacemaking current (If), wherein the cells are derived from mouse pluripotent embryonic stem cells by surrogate marker selection based on activity of the GATA6 promoter and enhancer, as set forth in SEQ ID No:

1.